Group | Treatment of experimental skin area once a day during 10 days | Treatment of intact skin area on 12th experiment day |
I | 2% solution of CoCl2 - 0.5 ml | 2% solution of CoCl2 - 0.5 ml |
II | MND 5.0 g・L−1 - 0.5 ml, after 2 h 2% solution of CoCl2 - 0.5 ml | 2% solution of CoCl2 - 0.5 ml |
III | MND 10.0 g・L−1 - 0.5 ml, after 2 h 2% solution of CoCl2 - 0.5 ml | 2% solution of CoCl2 - 0.5 ml |
IV | 5% solution of NiCl2 - 0.5 ml | 5% solution of NiCl2 - 0.5 ml |
V | MND 5.0 g・L−1 - 0.5 ml, after 2 h 5% solution of NiCl2 - 0.5 ml | 5% solution of NiCl2 - 0.5 ml |
VI | MND 10.0 g・L−1 - 0.5 ml, after 2 h 5% solution of NiCl2-0.5 ml | 5% solution of NiCl2 - 0.5 ml |
VII | 2.5% solution of K2Cr2O7 - 0.16 ml | 2.5% solution of K2Cr2O7 - 0.16 ml |
VIII | MND 5.0 g・L−1 - 0.5 ml, after 2 h 2.5% solution of K2Cr2O7 - 0.16 ml | 2.5% solution of K2Cr2O7 - 0.16 ml |
IX | MND 10.0 g・L−1 - 0.5 ml, after 2 h 2.5% solution of K2Cr2O7 - 0.16 ml | 2.5% solution of K2Cr2O7 - 0.16 ml |